Michele Spinetta

Speaker

Michele Spinetta

Corporate Market Research Head, Menarini

Michele Spinetta is the Corporate Market Research Lead at MENARINI Group, where he has spent over 20 years driving market insights and strategy. Before joining MENARINI, he worked in Market Research and as a Business Analyst at Novo Nordisk A/S, and held roles outside the pharmaceutical industry at companies such as ABN Amro and Microsoft.

Join Michele Spinetta
Book Now!

Session

How Are GenAI and LLM Tools Reshaping Competitive Intelligence in the Pharmaceutical Industry?

Panel Discussion

Monday, October 06

05:55 pm - 06:40 pm

Live in Berlin

Less Details

The emergence of Generative AI and Large Language Models (LLMs) is transforming how competitive intelligence is gathered, analyzed, and applied across industries. In pharmaceuticals—where regulation, data sensitivity, and scientific complexity are paramount—these technologies offer unprecedented opportunities and novel risks. This panel will explore how CI professionals can harness AI to gain actionable insights, maintain compliance, and stay ahead of market trends. Panelists will also discuss the strategic and operational implications of integrating these tools into CI workflows.

How is GenAI currently being used in competitive intelligence within the pharmaceutical industry? What are currently observed benefits, and what are the limits of these solutions?
What are the regulatory and compliance challenges when deploying GenAI in pharmaceutical CI processes?
How can CI teams ensure data quality, bias mitigation, and transparency when using GenAI-generated insights?
How to validate the results and differentiate reliable insights from AI hallucinations?
What organizational changes are needed to effectively integrate GenAI tools into CI functions?
How to organize and how to prepare the data for (any model of) AI?
Where and with which data should different AI/ML-based tools be used ideally – internally, externally or in a hybrid way?

Presentation

Company

Menarini

https://www.menarini.com/

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world.

Get Agenda

Book Now